Plasmodium parasites are causative agents of malaria, which affects Ͼ500 million people and claims ϳ2 million lives annually (1) . Rapid development of drug-resistant parasites and insecticide-resistant vectors necessitates discovery of novel drug and vaccine targets. Malaria infection is initiated in a human host when an infected Anopheles mosquito injects invasive sporozoites via the skin during a blood meal. Differential transcriptome profiling has identified ϳ25 Plasmodium genes that are specifically up-regulated in invasive sporozoites (2) . Two such genes, called UIS3 and UIS4, are critical for the establishment of blood stage infection in Plasmodium parasites (3) . UIS3-deficient parasites can start the transformation process in the liver; however, they show severe defects during transformation into trophozoites. Parasites lacking the gene for UIS3 are also unable to develop into mature liver schizonts and therefore abort malaria infection within the liver itself (3) . Crucially, immunization with UIS3-deficient sporozoites imparts complete protection against malaria in the rodent malaria model (3) .
UIS3 gene encodes a malaria parasite specific, unique, membrane-bound protein localized to the sporozoite parasitophorous vacuolar membrane (PVM) 4 (4) . The latter is a membranous network that surrounds the intracellular parasite, and it differs substantially from other membranous compartments like endosomes or phagolysosomes (5) . Interestingly, most of the fatty acids and lipids in the parasite PVM arise from the host cell, thus highlighting the fact that fatty acid/lipid import is crucial for parasite growth (5) . The PVM is further modified by insertion of parasite-encoded proteins (including UIS3 and UIS4), which together may regulate various transport activities between parasite and the host cytoplasm (4) . UIS3 appears to play a central role in fatty acid/lipid import during phases of rapid parasite growth (4) . The severe developmental defects evident in UIS3-deficient malaria parasites provide a rationale for dissecting the biochemical and structural attributes of UIS3. Abrogation of parasite growth and developmental arrest during the liver stages of malaria infection, by design of unique antimalarials that target the pathologically silent liver stages of the malaria life cycle, deserves renewed attention.
Studies using the yeast two-hybrid system and co-immunoprecipitation experiments have recently suggested that Plasmodium yoelii UIS3 protein is capable of binding to the mouse liver fatty acid-binding protein (LFABP) (4) . Down-regulation of mouse LFABP severely impaired development of rodent malaria parasites (4) . These data argue that delivery of fatty acid/lipid cargo from LFABP to UIS3 protein may be an important pathway for fatty acid/lipid import into the parasite. Mem-bers of the fatty acid-binding protein (FABP) family typically show affinity for both saturated and unsaturated fatty acids (6) . The LFABP differs from other members of FABP family in regards to its ligand binding stoichiometry (it can bind two independent chains of fatty acids) and in its ability to bind a spectrum of hydrophobic ligands (7) (8) (9) . Intracellular FABPs are composed of 10 stranded anti-parallel ␤-barrels with two short anti-parallel ␣-helices positioned over one end of the ␤-barrel (10). The crystal structure of rat LFABP reveals the same conserved FABP fold but with structural differences that dramatically alter ligand specificities (6) . Rat LFABP possesses two ligand-binding sites in different environments in terms of fatty acid burial within the protein (6) . Crucially, the carboxylate group of second oleate in LFABP appears to be fully solventaccessible (6) . The liver FABPs are also capable of interacting with lysophospholipids in a stoichiometric ratio of 1:1.
The obligate nature of UIS3 gene for sporozoite development and interaction of UIS3 with LFABP together suggest parasite reliance on fatty acid/lipid acquisition from host hepatocytes (4) . The rapidly growing population of liver stage parasites probably requires excessive amounts of lipids for membrane biogenesis, and UIS3-LFABP cross-talk may provide such conduits. We present here a detailed structure-function dissection of the PfUIS3 130 -229 -phosphatidylethanolamine complex and provide evidence for direct interaction of PfUIS3 130 -229 with phospholipid vesicles and with human LFABP. These studies lay a foundation for the development of specific inhibitors that may block development of the parasite in infected host liver before pathological symptoms of malaria infection appear.
EXPERIMENTAL PROCEDURES

Molecular Cloning, Expression, and Purification of PfUIS3-
The UIS3 gene from Plasmodium falciparum (GenBank TM accession number XM_001349714; PlasmoDB number PF13_0012) was PCR-amplified from a sporozoite cDNA library. The amplified fragment (residues 83-229) was cloned between BamHI and SalI restriction sites in pGEX4T1 vector and the protein expressed in fusion with GST. For production of selenium-methionine-labeled protein, Escherhichia coli B834 (DE3) cells were freshly transformed, and a single colony was grown in 10 ml of minimal medium supplemented with 0.2% (w/v) glucose, 50 g ml Ϫ1 carbenicillin, and all amino acids including selenomethionine (except Met and Cys) (11) . After 24 h of growth, this seed culture was used to inoculate a 1-liter culture that was grown for 20 h at 37°C. Protein expression was induced by the addition of 1 mM isopropyl ␤-D-thiogalactopyranoside, and the culture was grown for 12 h postinduction. The resulting bacterial pellet from this 1-liter culture was suspended in 40 ml of PBS, pH 7.4, supplemented with lysozyme (100 g ml Ϫ1 ) and protease inhibitor mixture. The cells were sonicated and cleared by centrifugation at 20,000 ϫ g. The cleared supernatant was passed through glutathione-Sepharose beads, which were then washed with PBS to remove impurities. PfUIS3-GST fusion protein was directly subjected to thrombin cleavage at 20°C for 8 h on the beads. Cleaved PfUIS3 protein was subsequently collected as flow through, and the thrombin in solution was inactivated by benzamidine treatment (final concentration, 2 mM). Eluted PfUIS3 was concentrated using a 5-kDa Centricon (Viva Biosciences) after gel filtration chromatography. The purified protein was buffer-exchanged in crystallization buffer (10 mM Tris-HCl, pH 8.0, 25 mM NaCl, and 0.02% NaN 3 ), and crystallization experiments were set. For cross-linking experiments, a total of 5 g of PfUIS3 was incubated with 0.1% of glutaraldehyde for 1 h at room temperature, and the reaction was stopped using Laemmli buffer. The samples were boiled and loaded on SDS-PAGE and visualized using Coomassie staining.
Crystallization, Data Collection, and Structure Determination-Selenium-labeled PfUIS3 130 -229 crystals were obtained at 20°C by hanging drop vapor diffusion method using 1 l each of PfUIS3 130 -229 (10 mg ml Ϫ1 ) and 0.1 M MES, pH 6.5, 12% polyethylene glycol 20,000, 0.01 M dithiothreitol (mother liquor). A single needle-shaped crystal was flash frozen under a stream of nitrogen gas at 100 K using mother liquor supplemented with 20% glycerol as a cryoprotectant. X-ray diffraction data were collected on a MARCCD detector at the BM14 beam line of the European Synchrotron Radiation Facility. A selenium single-wavelength anomalous dispersion data set to 2.5 Å resolution was collected, and diffraction images were processed and scaled with the HKL2000 suite program (12) . All of the 18 expected selenium sites were found, both by AutoSol in Phenix and by SHELXD. PfUIS3 130 -229 crystals are monoclinic and belong to space group P2 1 ( Table 1 ). The structure was determined using PHENIX (13) with selenium single-wavelength anomalous dispersion data set. Initial model was built by PHE-NIX, and this model was subsequently rebuilt using COOT (14) . Model refinement was performed using REFMAC (15) without imposing NCS restraints. This was done so that conformations of the six molecules in the asymmetric unit could be determined independently (Table 1) . During the course of sample using a chloroform-methanol (2:1) mixture. The organic layer was washed with water and dried under nitrogen. Phospholipid extracts were then resuspended in chloroform:methanol (2:1) mixture. Electron spray ionization analysis was then done in negative polarity mode, which was calibrated externally.
Preparation of Phospholipid Liposome Vesicles-Liposomes were prepared by a sonication method (16) using commercially available lipids. In brief, 1:1.2 molar ratios of 1,2-dipalmitoylsn-glycero-3-phosphocholine, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, and cholesterol were used for liposome preparation. The lipid mixture was added to a 50-ml roundbottomed flask and dissolved in diethyl ether, and the system was kept under a stream of nitrogen gas. One-third of the total volume equivalent PBS was added to the above, and the mixture was sonicated briefly to obtain a clear suspension. Subsequently, the organic solvent was evaporated under reduced pressure on a rotatory evaporator. An excess of PBS was added at this stage, and the system was again kept under reduced pressure for 15-20 min so as to remove any traces of organic solvent. The suspension thus obtained was sonicated for 15-20 min on ice, and the resulting clear suspension was filtered through a 0.2-m Acrodisc syringe filter (PALL Life Sciences) for maintaining homogeneity. These liposomes were characterized by dynamic light scattering and stored at 4°C.
Circular Dichroism and Dynamic Light Scattering Experiments-For CD analysis of PfUIS3
130 -229 -liposomes interactions, the protein was first dialyzed against 5 mM NaH 2 PO 4, 5 mM Na 2 HPO 4 , and 5 mM NaCl, pH 7.0. Far UV spectra (190 -240 nm) of PfUIS3 130 -229 (0.1 mg/ml) were recorded at 20°C in a 1-mm-path length cell with a JASCO-810 spectrophotometer. Scanning speed of 50 nm/min was used, and the instrument was continuously purged with nitrogen to prevent ozone accumulation. The spectra were measured 5-fold and averaged, and the base line was corrected by subtraction of blank buffer. For studying the effect of liposome addition on the overall structure of PfUIS3 130 -229 , the liposomes were titrated, and CD spectra were recorded. Bovine serum albumin (BSA), proteinase K, and lysozyme were used as controls. Similarly, freshly prepared liposomes were used for dynamic light scattering analysis using a Photocor-Complex machine at a scattering angle of 90°. Linear correlation function was generated with a sample time of 30 s. Size distribution of liposomes was studied by titrating liposomes with PfUIS3 130 -229 . Increasing amounts of PfUIS3 130 -229 protein were added to the liposomes and incubated at 20°C for 10 -15 min. The samples were then analyzed for mean hydrodynamic radius through light scattering. BSA and proteinase K were used as control proteins.
Cloning, Expression, and Purification of Human LFABPCodon-optimized LFABP (GeneArt) was cloned in PET28a modified vector by using KpnI and NcoI restriction sites and then transformed in E. coli B834 host cells. The clones were confirmed by DNA sequencing, and then one was used for inoculation of 10 ml of LB containing ampicillin antibiotic at 37°C until it reached the log phase. This starter was used as seed culture for inoculation of 1 liter of LB with ampicillin (100 g/ml). 1 mM isopropyl ␤-D-thiogalactopyranoside was used for induction of culture at an optical density of 0.6, and the culture was grown at 37°C for 5 h. Protein was affinity purified using a nickel-chelating column (Pharmacia) and also by gel filtration using a S75 column (Pharmacia).
PfUIS3-LFABP Binding Studies-PfUIS3-LFABP interaction was studied using purified proteins and plate-based ELISAs. 150 ng of purified PfUIS3 was coated on wells of a 96-well microtiter plate in bicarbonate buffer overnight at 4°C in quadruplicates. The protein gelatin (Sigma) was used as a negative control. After incubation, the plates were washed with PBS, 0.2% Tween 20 (PBST) and blocked with 3% PBS-gelatin (200 l/well) for 2 h at 37°C. After blocking, 100 l of different amounts of His-tagged LFABP (concentrations ranging from 50 to 400 ng) in PBS was used for binding with the plate bound PfUIS3. After 1 h of incubation at 37°C, extensive washings were done, and the reactions were incubated with 1:4000 dilution of anti-His horseradish peroxidase antibody (Sigma) in 3% gelatin for 1 h at 37°C. After three more PBST washes, a color reaction was developed using orthophenylenediamine (Sigma) and H 2 O 2 in citrate-phosphate buffer. The optical density was measured at 490 nm using an ELISA plate reader (Molecular Probes). An average of four experiments was plotted after deducting background signal from the negative control (Gelatin). Standard deviations were less than 10% in all the cases.
RESULTS
PfUIS3
Production and Oligomeric State-UIS3 gene encoding for residues spanning the PfUIS3 soluble domain (83-229) (without the signal sequence, cytoplasmic tail, and the membrane anchor) was expressed in a bacterial overexpression system. Purified PfUIS3 (residues 83-229) was dimeric in solution as shown by protein cross-linking experiments and gel filtration chromatography (Fig. 1) . Dimeric PfUIS3 (residues 83-229) failed to crystallize despite extensive screening; however, a monomeric form (residues 130 -229) of PfUIS3 crystallized rapidly. Analysis of the PfUIS3 dimer-monomer transition using gel filtration chromatography and SDS-PAGE suggested that dimeric PfUIS3 underwent proteolysis and reduced to a stable, soluble domain spanning residues 130 -229 (Fig. 1a) . This suggests that residues within residues 83-129 of PfUIS3 are likely to be involved in dimerization of PfUIS3. From here on, this soluble domain will be referred to as PfUIS3 -PE complex has R work and R free values of 22 and 27%, respectively ( Table 1 ). The refined model has excellent stereochemistry and contains 135 water molecules and six PE molecules. Data processing and refinement statistics are summarized in Table 1 .
The superposition of C ␣ atoms of the six monomers (A to F) of PfUIS3 130 -229 in the asymmetric unit gives an root mean square deviation of ϳ0.5 Å. There is no noncrystallographic point group symmetry found between the six PfUIS3 turn T2 (179 -181) connects ␣-helix H2 with ␣-helix H3 (182-196). Finally, turn T3 (197-201) connects ␣-helix H3 to terminal ␣-helix H4 (202-227) (Fig. 2) . PfUIS3 130 -229 fold is highly reminiscent of the ubiquitous helix-turn-helix motifs, and sequence comparison of UIS3 homologs from various plasmodial species suggests a high level of conservation (Fig. 3) . The PfUIS3 surface has a spatially distinct opposite charge character. A broad negatively charged patch is evident on one face of PfUIS3 130 -229 , which contains many charged residues, particularly Glu 228 , Glu 227 , Asp 176 , and Asp 173 (Fig. 4a) . The phospholipid range in time-of-flight MS analysis was between 680 and 780 daltons. The shown tandem MS analysis of 716 daltons at collision energy 40 eV for 5 min shows expected fragments of PE. These data indicated the presence of 1-palmitoyl-2-oleoyl-phosphatidylethanolamine at a molecular size of 716 daltons (Fig. 5b) bound to PfUIS3 130 -229 . This is consistent with the fact that phosphatidylethanolamine is an abundant lipid of E. coli and constitutes ϳ75% of membrane lipids (17) . Given that PfUIS3 was overexpressed in E. coli, it is therefore likely that PE was nat- urally bound during UIS3 overproduction within the bacterial cell, as has been found in many previous studies of fatty acidbinding proteins. Confirmation of ligand identity by mass spectrometry allowed us to model PE molecules into the extra density on the surface of PfUIS3 130 -229 . Structure of PE (Protein Data Bank entry 1lqv) shows a remarkable fit in the Y-shaped density and makes close contacts with side chains emanating from PfUIS3 130 -229 (Figs. 5a and 6 ). We were able to model PE phosphate head groups for each of the six monomers of PfUIS3 130 -229 in the asymmetric unit. The excellent quality of difference and 2F o Ϫ F c maps allowed us to model three complete and three partial chains of PE. The models were refined using crystallographic data to 2.5 Å resolution, and R free was monitored throughout the course of model building and refinement of the PfUIS3 130 -229 -PE complex described here.
PfUIS3 130 -229 forms a 1:1 complex with phosphatidylethanolamine as is evident from the structure (Fig. 6) (Fig. 6c) . These residues participate in hydrogen bonds to stabilize the phosphate head group of PE (Fig. 6c) highlights a narrow, surface-exposed, hydrophobic channel that accommodates one acyl chain of PE (Fig. 6a) . One end of this channel is polar and makes a binding site for zwitterionic head group of phospholipids PE (Fig. 6b) (Fig. 6d) . These polar residues are engaged in hydrogen-bonding networks, and their hydrophobic stems seem to provide the apolar environment for acceptance of the PE acyl chain. Closer inspection of above interactions (using reference chain C of PfUIS3 neighboring PfUIS3 130 -229 chain seem to stabilize the second acyl chain of PE (Fig. 6d) .
Surface lipophilicity analysis of PfUIS3 reveals the presence of a lipophilic channel very near to PE binding channel (Fig.  7) .This channel is lined by residues Leu 134 , Ile 132 , Phe 188 , Leu 192 , Leu 158 , and Leu 161 , which are largely conserved in all the plasmodial UIS3. The biological significance of this channel is not fully clear, but it seems that it may also act as a binding site for hydrophobic cargo.
PfUIS3 130 -229 residues that make close contact with the PE head group show some degree of sequence conservation in Plasmodial UIS3s, specifically, in a conserved ability to participate in network of hydrogen bonds (Fig. 3) . It may be that PfUIS3 family members have necessarily limited capacity to differentiate between various lipids and fatty acids; UIS3 proteins may act as generic fatty acid/lipid adaptors with the general ability to recognize and bind a variety of lipid-like cargo that the growing parasite might require. This lack of specificity will manifest itself in limited sequence conservation that will therefore allow a wider array of lipid-like ligands to be bound and transported. -lipid/fatty acid interactions were further probed using two independent biophysical techniques. We performed CD experiments using far UV (240 -190 nm) on purified PfUIS3 130 -229 (monomer)-liposome complexes. A titration study indicated distinct and specific conformational changes in PfUIS3 130 -229 in the presence of liposomes (Fig. 8a) . Interaction with liposomes seems to decrease the helical content of PfUIS3 130 -229 in favor of random coil (Fig. 8, a and  b) , suggesting increased disorder in the protein. A plot of ellipticity as a function of liposome concentration at 208 nm (Fig. 8c ) and 222 nm (Fig. 7d) PfUIS3 130 -229 Binds Human Liver Fatty Acid-binding ProteinThe rodent malaria parasite homolog of PfUIS3, PyUIS3, is known to interact with mouse liver fatty acid-binding protein as shown previously by yeast two-hybrid screens and co-immunoprecipitation experiments (4). Not surprisingly, we found that the homolog of PyUIS3 in P. falciparum interacts with the human counterpart of rodent LFABP. Our evidence for PfUIS3 130 -229 -human FABP interaction is based on purified components used in protein-protein based ELISAs (Fig. 10) . The binding between PfUIS3 130 -229 and human LFABP was specific and dose-dependent. Further, this experiment clearly suggests that the recognition site for human LFABL on PfUIS3 resides within the monomeric 130 -229 spanning domain.
DISCUSSION
Recent genomic data on malaria parasite liver stages provide a new rationale for the development of sporozoite-spe- cific inhibitors that abrogate malaria infection in the liver. After sporozoite invasion of the host liver cell, molecular components from the latter are used for synthesis of vital parasite structural features like the parasitophorous vacuolar membrane (5) . Although the malaria parasite is able to synthesize fatty acids through an apicoplast-based biosynthesis pathway (18) , it seems that during hepatocytic stages, the parasite relies on host fatty acids for rapid synthesis of its membranes (4, 18) . A host of proteins (like UIS3) are therefore inserted in the PVM to enable import of essential nutrients (4, 19) . Genetic interference with these transport pathways is often deleterious to the parasite, as has been already shown for UIS3-and UIS4-deficient parasites (3). UIS3 is a membrane protein with distinct transmembrane and soluble domains. Sequence analysis of PfUIS3 suggests that residues 1-21 form its signal sequence, residues 22-59 entail the cytosolic region, whereas its transmembrane region is formed by residues 60 -83 (3). The overall domain architecture of PfUIS3 suggests that the soluble region of PfUIS3 (89 -229) is exposed to the contents of the hepatocyte cytoplasm. Our biochemical data indicate that the PfUIS3 region spanning residues 89 -229 is soluble and dimeric in solution, whereas truncation of PfUIS3 to the 130 -229 segment abolishes its dimerization property. The oligomerization domain is therefore contained within the region from residues 89 to 129 and indicates that PfUIS3 exists as two subdomains, a dimerization subdomain (residues 89 -129) and a large fourhelical bundle subdomain (residues 130 -229).
We solved the crystal structure of PfUIS3 130 -229 in complex with a bound phospholipid molecule. The surface of PfUIS3 130 -229 has spatially distinct areas of positive and negative charge density, and it displays a hydrophobic channel where one acyl arm of PE is able to bind (Figs. 5 and 6 ). The phosphate head group of bound PE in PfUIS3 130 -229 -PE complex structure forms specific hydrogen bonding interactions with several polar residues at one end of hydrophobic channel. A conserved water molecule is also involved in these interactions (Fig. 6) . The architecture of this binding site hints that a large repertoire of phospholipid/fatty acid molecules can bind in this cavity because only residues interacting with the phosphate head group of PE were conserved in their characteristics of forming hydrogen bond networks. Aside from these structural insights, two sets of biophysical experiments using liposomes and pure PfUIS3 130 -229 clearly highlight the ability of PfUIS3 130 -229 to form specific complexes with liposomes and conformational changes in PfUIS3 130 -229 upon binding of liposomes. We also studied the direct interaction of PfUIS3 130 -229 with human LFABP, which is in agreement with the previous findings with the rodent homolog of PfUIS3 (4).
Our present study provides crucial evidence that PfUIS3 may itself act as a fatty acids/lipid carrier given that it is capable of interacting directly with phospholipids and liposomes. This ability of PfUIS3 is in addition to its interaction with LFABP. Therefore, PfUIS3 may participate in lipid exchange by sequestering the FABP cargo for forward passage to the membrane on which PfUIS3 resides. A stepwise mechanism probably exists where fatty acid/lipids carried by LFABP are initially transferred to PfUIS3, which subsequently delivers them to the PVM, from where they may be internalized into the parasite. The region of PfUIS3 from residues 83 to 129 is predicted to be random coiled coil, which is known to be flexible. This linker region might provide a flexible hinge for interaction of PfUIS3 130 -229 -PE-FABP complex with the PVM. Our structural and functional data provide new insights into the role of PfUIS3 in the transfer of hydrophobic cargo from host cytoplasm/FABP to and through the parasite PVM.
Within the family of well characterized FABPs, those capable of "collisional transfer" (like the intestinal FABP) can interact directly with membranes during fatty acid transfer (22) . The ␣-helix (␣1) of collisional FABPs is amphipathic in nature and may assist in lipid transfer. On the other hand, liver FABPs do not employ collisional mechanism of fatty acid transfer (10, 20) . An analysis of surface electrostatic potentials for several FABPs demonstrates a net positive potential across the helix-turn-helix portal region of colliosional transfer FABPs, which supports the suggestion that this region is involved in interaction with membranes (10, 21, 22) . On the other hand, human liver FABP contains three conserved acidic residues that emanate from its helix turn helix portal and form a distinct negative patch on its surface from where fatty acid shuttling is likely to be triggered (23) . However, the liver FABPs are inefficient at transferring fatty acids/lipids to membranes and may therefore require additional protein adaptors (like PfUIS3) to assist in unloading of lipid-like luggage on to the membrane network. These insights underpin the significance of both LFABP and PfUIS3 in lipid/fatty acid ingress for the parasite. We propose that liver FABPs may interact with UIS3s in a dynamic and continuous process of cargo transfer. This scenario is in contrast to FABPs of the intestinal variety that employ the collisional transfer mechanism and are therefore more efficient at off-loading their ligands directly to membranes, without protein or molecular intermediaries.
In the aqueous environment of the liver hepatocyte cytosol, the presence of free fatty acids is unlikely because of their hydrophobic character. The parasite seems to have therefore developed molecular machinery that can act as a conduit for stepwise capture and transfer of fatty acid, thereby obviating the requirement for extensive lipid synthesis within the parasite. The likely mechanism of interaction (Fig. 11) , based on structures of LFABP and PfUIS3 130 -229 may be: (a) LFABP shuttles fatty acids/lipids from host cytoplasm to UIS3, (b) UIS3 binds directly to LFABP and captures its cargo in a continuous and dynamic fashion, (c) UIS3 ligand-binding sites undergo conformational changes to accommodate fatty acids/lipids, and finally, (d) similar to the collisional transfer mechanism used by other fatty acid transporters, the membrane tethered UIS3 releases its cargo directly on to the parasite PVM. Repetition of this transfer cycle will ensure a ready supply of LFABP cargo to the growing parasite within the host liver 130 -229 to human LFABP. Protein-protein based ELISAs were performed as described under "Experimental Procedures." Each experiment was performed in quadruplicate, and an average of four experiments was plotted after deducting the background signal from the negative control (Gelatin). The standard deviations were less than 10% in all cases. SDS-PAGE of purified PfUIS3 and LFABP used in these ELISAs are shown as insets in the figure. cell; the absence of UIS3 therefore robs the parasite of a molecular intermediary capable of scavenging LFABP cargo.
It seems feasible to specifically block the interaction of fatty acids/lipids with their carrier proteins using small molecule inhibitors (24) . This has been recently been shown by development of human fatty acid-binding-protein aP2 inhibitors, which may be useful in treatment of diabetes and atherosclerosis (24) . Our high resolution structural analysis of PfUIS3 130 -229 -PE complex provides a structural framework for initiating development of small molecule mimics that can target molecular functions of PfUIS3. Disruption of PfUIS3 interactions with lipids/fatty acids/FABP by employment of molecular agents may lead to developmental arrest of sporozoites in the host liver. Such inhibitory agents may serve as prophylactics and prevent egress of malaria parasites from the infected liver. Inhibiting molecular functions of UIS3 may therefore target malaria parasite before the initiation of erythrocytic stages, prior to the onset of symptomatic malaria.
